Healthy
Conditions
Keywords
dietary fibre, legumes, lupin kernel fibre, soy fibre, bile acids, short-chain fatty acids, cholesterol metabolism, Subjects
Brief summary
The objective of the conducted study was to determine the efficacy of the native legume kernel fibres of Lupinus angustifolius Boregine (Boregine), Lupinus albus Typ Top (TypTop) and Glycine max Hefeng (Soy fibre) on prevention of risk factors for gastrointestinal or cardiovascular diseases.
Detailed description
Dietary fibre is suspected to effect the faecal concentration and excretion of bile acids by binding the bile acids and by increasing the faecal mass. Bile acids, especially the secondary bile acids, are potential risk factors for colorectal cancer. A high bile acid-binding ability of fibre could lead to lower serum cholesterol concentrations by interrupting the enterohepatic circulation. There is evidence that the consumption of legume kernel fibre, containing both soluble and insoluble fibre fractions, may beneficially modify bowel health. Seventy-eight healthy volunteers were enrolled. Seventy-six subjects (mean age of 24 years, 55 women and 21 men) completed the double-blind, randomized crossover trial. After two weeks run-in period, half of the volunteers consumed 25 g of legume fibres (Boregine, TypTop or Soy fibre) every day, and the other half received a reference fibre product (citrus fibre, Herbacel AQ Plus) for a period of two weeks. After two weeks wash-out the intervention changed between the groups. At the end of each period a quantitative stool and urine collection took place and fasting blood samples were drawn.
Interventions
The subjects consumed 25 g pure fibre-product per day over two weeks. One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
The subjects consumed 25 g reference fibre (citrus fibre: Herbacel AQ Plus; Herbafood Ingredients) per day over two weeks. One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
Sponsors
Study design
Eligibility
Inclusion criteria
* age 20-45 years * healthy subjects
Exclusion criteria
* intake of pharmaceuticals and nutritional supplements * allergy against legumes * intolerance against milk protein * pregnancy, lactation * chronic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes of serum lipids (cholesterol metabolism) | after 2, 4 and 8 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Changes of general excretion parameters, neutral sterols, bile acids, short-chain fatty acids, fibre excretion | after 2, 4 and 8 weeks |
Countries
Germany